Needham Reiterates Hold on Zimmer Biomet Holdings
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH).
September 17, 2024 | 9:42 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Mike Matson has reiterated a Hold rating on Zimmer Biomet Holdings, indicating a neutral stance on the stock.
The reiteration of a Hold rating by Needham suggests that the analyst sees no immediate catalysts for significant price movement in Zimmer Biomet Holdings. This neutral stance implies that investors should neither expect a strong upward nor downward movement in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100